29914956-figure-01 (29914956 Figure 01)
Fosinopril Sodium
Product Images NDC 63629-5279
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 63629-5279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
29914956-figure-02 (29914956 Figure 02)
This is a table showing the incidence and discontinuation of clinical adverse events in placebo-controlled trials for hypertension using Fosinopril Sodium and Placebo. The table displays three adverse events: cough, dizziness, and nausea/vomiting. The incidence of cough for Fosinopril Sodium was 22 and the incidence for placebo was 0. The incidence of dizziness for Fosinopril Sodium was 16 and the incidence for placebo was also 0. The incidence of nausea/vomiting for Fosinopril Sodium was 12 and the incidence for placebo was 5. Discontinuation data is also included.*
29914956-figure-03 (29914956 Figure 03)
This is a table summarizing the incidence and discontinuation rates of various symptoms in a placebo group of a heart failure trial. The symptoms include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, and diarrhea. The numbers in parentheses represent the number of patients who discontinued the trial due to that symptom.*
29914956-figure-04 (29914956 Figure 04)
This is a comparison of the incidence and discontinuation rates of side effects between two groups of patients, one given Fosinopril Sodium and another given a placebo. The text lists the specific side effects and their rates, including Chest Pain (non-cardiac), Upper Respiratory Infection, Orthostatic Hypotension, Subjective Cardiac Rhythm Disturbance, and Weakness. The numbers in parentheses indicate the rate of discontinuation due to the side effect.*
Label (52791)
This is a medication called Fosinopril, packaged in a bottle containing 30 tablets, each tablet containing 10mg of Sodium. It is intended to be a cheaper alternative to Monopril 10mg Tablet, manufactured by Canber Pharmceutia. The product was packaged on behalf of Bryant Reck and has an expiration date of MM/YY. The tablets are small, round, and white, with the label "16200" imprinted on them. The medication should be stored in a light-resistant container and kept in a room temperature environment between 20-25°C (68-77°F). The NDC number is 6362952791, and the product code is 05279171109.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
